Issuing a so-called positive opinion ... marketing authorization for vilobelimab as treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome who are receiving ...

Researchers at the La Jolla Institute for Immunology in California took blood from 20 adults who’d recovered from COVID-19 and exposed the samples to proteins from the SARS-CoV-2 virus. All of the ...

As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely emerge, driven by positive selection for traits such as increased ...

The RNA of inflamed epithelial and activated immune cells can reveal what the patient’s immune system is doing in response to the virus. This could help researchers understand how SARS-CoV-2 ...

SARS-CoV-2-Reactive T Cells Found in Patients with Severe COVID-19 A small subset of uninfected people also had SARS-CoV-2-fighting T cells, a finding that scientists are still trying to figure out.

Pediatric patients with prior SARS-CoV-2 infection had a higher risk of adverse postacute kidney outcomes, such as new-onset ...

As part of the SCORPIO-PEP double-blind, placebo-controlled trial, Hayden and colleagues enrolled 2,389 household contacts of index patients with COVID-19 who had tested negative for SARS-CoV-2 ...

The pink line represents patients who developed persistent ... Overall, 2.6% of all SARS-CoV-2-positive individuals reported prolonged shortness of breath, 10.4% experienced long-lasting fatigue ...